[Pulmonary and cardiovascular syndrome due to hantavirus: clinical aspects of an emerging disease in southeastern Brazil]

Rev Soc Bras Med Trop. 2009 May-Jun;42(3):282-9. doi: 10.1590/s0037-86822009000300009.
[Article in Portuguese]

Abstract

Pulmonary and cardiovascular syndrome due to hantavirus is a disease caused by inhalation of aerosols from the excreta of wild rodents contaminated by viruses of the Bunyaviridae family. We studied the clinical and laboratory manifestations of 70 cases that occurred in the region of Ribeirão Preto, SP, Brazil, between 1998 and 2007. The frequency of symptoms was as follows: dyspnea (87%), fever (81%), coughing (44%), headache (34%), tachycardia (81%), low arterial blood pressure (56%), metabolic acidosis (57%), lymphocytopenia (51%), hematocrit > 45% (70%), leukocytosis with left deviation (67%), creatinine (51%) and urea (42%). Mortality (54.3%) occurred mainly on the fourth day. Respiratory insufficiency, low arterial blood pressure and shock occurred after 24 to 48 hours. High hematocrit and decreased platelet levels were signs strongly suggestive of the disease. The diagnostic hypothesis of atypical pneumonia was associated with a good prognosis (p = 0.0136). Fluid infusion greater than 2,000 ml and arterial hypotension were associated with a poor prognosis (p = 0.0286 and p = 0.0453).

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Brazil / epidemiology
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / mortality*
  • Cardiovascular Diseases / therapy
  • Cardiovascular Diseases / virology
  • Communicable Diseases, Emerging / diagnosis
  • Communicable Diseases, Emerging / mortality*
  • Communicable Diseases, Emerging / therapy
  • Communicable Diseases, Emerging / virology
  • Female
  • Hantavirus Pulmonary Syndrome / diagnosis
  • Hantavirus Pulmonary Syndrome / mortality*
  • Hantavirus Pulmonary Syndrome / therapy
  • Humans
  • Incidence
  • Male
  • Prognosis
  • Retrospective Studies
  • Young Adult